Dopaminergic Treatment Effects on Dysarthric Speech: Acoustic Analysis in a Cohort of Patients With Advanced Parkinson's Disease
Importance: The effects of dopaminergic treatment on speech in patients with Parkinson's disease (PD) are often mixed and unclear. The aim of this study was to better elucidate those discrepancies.Methods: Full retrospective data from advanced PD patients before and after an acute levodopa chal...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-02-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2020.616062/full |
id |
doaj-c6bf173dc2014c8a8061c8e44d0e9af6 |
---|---|
record_format |
Article |
spelling |
doaj-c6bf173dc2014c8a8061c8e44d0e9af62021-02-05T06:39:11ZengFrontiers Media S.A.Frontiers in Neurology1664-22952021-02-011110.3389/fneur.2020.616062616062Dopaminergic Treatment Effects on Dysarthric Speech: Acoustic Analysis in a Cohort of Patients With Advanced Parkinson's DiseaseFrancesco Cavallieri0Francesco Cavallieri1Carla Budriesi2Carla Budriesi3Annalisa Gessani4Annalisa Gessani5Sara Contardi6Sara Contardi7Valentina Fioravanti8Elisa Menozzi9Elisa Menozzi10Elisa Menozzi11Serge Pinto12Elena Moro13Franco Valzania14Francesca Antonelli15Francesca Antonelli16Neurology Unit, Neuromotor and Rehabilitation Department, Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, ItalyClinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, ItalyDepartment of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, ItalyAzienda Ospedaliero Universitaria di Modena, Modena, ItalyDepartment of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, ItalyAzienda Ospedaliero Universitaria di Modena, Modena, ItalyDepartment of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, ItalyAzienda Ospedaliero Universitaria di Modena, Modena, ItalyNeurology Unit, Neuromotor and Rehabilitation Department, Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, ItalyDepartment of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, ItalyAzienda Ospedaliero Universitaria di Modena, Modena, ItalyDepartment of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, United KingdomAix Marseille Univ, CNRS, LPL, Aix-en-Provence, FranceDivision of Neurology, Centre Hospitalier Universitaire (CHU), Grenoble Alpes University, Grenoble Institute of Neurosciences, Grenoble, FranceNeurology Unit, Neuromotor and Rehabilitation Department, Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, ItalyDepartment of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, ItalyAzienda Ospedaliero Universitaria di Modena, Modena, ItalyImportance: The effects of dopaminergic treatment on speech in patients with Parkinson's disease (PD) are often mixed and unclear. The aim of this study was to better elucidate those discrepancies.Methods: Full retrospective data from advanced PD patients before and after an acute levodopa challenge were collected. Acoustic analysis of spontaneous monologue and sustained phonation including several quantitative parameters [i.e., maximum phonation time (MPT); shimmer local dB] as well as the Unified Parkinson's Disease Rating Scale (UPDRS) (total scores, subscores, and items) and the Clinical Dyskinesia Rating Scale (CDRS) were performed in both the defined-OFF and -ON conditions. The primary outcome was the changes of speech parameters after levodopa intake. Secondary outcomes included the analysis of possible correlations of motor features and levodopa-induced dyskinesia (LID) with acoustic speech parameters. Statistical analysis included paired t-test between the ON and OFF data (calculated separately for male and female subgroups) and Pearson correlation between speech and motor data.Results: In 50 PD patients (male: 32; female: 18), levodopa significantly increased the MPT of sustained phonation in female patients (p < 0.01). In the OFF-state, the UPDRS part-III speech item negatively correlated with MPT (p = 0.02), whereas in the ON-state, it correlated positively with the shimmer local dB (p = 0.01), an expression of poorer voice quality. The total CDRS score and axial subscores strongly correlated with the ON-state shimmer local dB (p = 0.01 and p < 0.01, respectively).Conclusions: Our findings emphasize that levodopa has a poor effect on speech acoustic parameters. The intensity and location of LID negatively influenced speech quality.https://www.frontiersin.org/articles/10.3389/fneur.2020.616062/fullacoustic analysisdysarthriadyskinesiaslevodopaParkinson's diseasespeech |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Francesco Cavallieri Francesco Cavallieri Carla Budriesi Carla Budriesi Annalisa Gessani Annalisa Gessani Sara Contardi Sara Contardi Valentina Fioravanti Elisa Menozzi Elisa Menozzi Elisa Menozzi Serge Pinto Elena Moro Franco Valzania Francesca Antonelli Francesca Antonelli |
spellingShingle |
Francesco Cavallieri Francesco Cavallieri Carla Budriesi Carla Budriesi Annalisa Gessani Annalisa Gessani Sara Contardi Sara Contardi Valentina Fioravanti Elisa Menozzi Elisa Menozzi Elisa Menozzi Serge Pinto Elena Moro Franco Valzania Francesca Antonelli Francesca Antonelli Dopaminergic Treatment Effects on Dysarthric Speech: Acoustic Analysis in a Cohort of Patients With Advanced Parkinson's Disease Frontiers in Neurology acoustic analysis dysarthria dyskinesias levodopa Parkinson's disease speech |
author_facet |
Francesco Cavallieri Francesco Cavallieri Carla Budriesi Carla Budriesi Annalisa Gessani Annalisa Gessani Sara Contardi Sara Contardi Valentina Fioravanti Elisa Menozzi Elisa Menozzi Elisa Menozzi Serge Pinto Elena Moro Franco Valzania Francesca Antonelli Francesca Antonelli |
author_sort |
Francesco Cavallieri |
title |
Dopaminergic Treatment Effects on Dysarthric Speech: Acoustic Analysis in a Cohort of Patients With Advanced Parkinson's Disease |
title_short |
Dopaminergic Treatment Effects on Dysarthric Speech: Acoustic Analysis in a Cohort of Patients With Advanced Parkinson's Disease |
title_full |
Dopaminergic Treatment Effects on Dysarthric Speech: Acoustic Analysis in a Cohort of Patients With Advanced Parkinson's Disease |
title_fullStr |
Dopaminergic Treatment Effects on Dysarthric Speech: Acoustic Analysis in a Cohort of Patients With Advanced Parkinson's Disease |
title_full_unstemmed |
Dopaminergic Treatment Effects on Dysarthric Speech: Acoustic Analysis in a Cohort of Patients With Advanced Parkinson's Disease |
title_sort |
dopaminergic treatment effects on dysarthric speech: acoustic analysis in a cohort of patients with advanced parkinson's disease |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Neurology |
issn |
1664-2295 |
publishDate |
2021-02-01 |
description |
Importance: The effects of dopaminergic treatment on speech in patients with Parkinson's disease (PD) are often mixed and unclear. The aim of this study was to better elucidate those discrepancies.Methods: Full retrospective data from advanced PD patients before and after an acute levodopa challenge were collected. Acoustic analysis of spontaneous monologue and sustained phonation including several quantitative parameters [i.e., maximum phonation time (MPT); shimmer local dB] as well as the Unified Parkinson's Disease Rating Scale (UPDRS) (total scores, subscores, and items) and the Clinical Dyskinesia Rating Scale (CDRS) were performed in both the defined-OFF and -ON conditions. The primary outcome was the changes of speech parameters after levodopa intake. Secondary outcomes included the analysis of possible correlations of motor features and levodopa-induced dyskinesia (LID) with acoustic speech parameters. Statistical analysis included paired t-test between the ON and OFF data (calculated separately for male and female subgroups) and Pearson correlation between speech and motor data.Results: In 50 PD patients (male: 32; female: 18), levodopa significantly increased the MPT of sustained phonation in female patients (p < 0.01). In the OFF-state, the UPDRS part-III speech item negatively correlated with MPT (p = 0.02), whereas in the ON-state, it correlated positively with the shimmer local dB (p = 0.01), an expression of poorer voice quality. The total CDRS score and axial subscores strongly correlated with the ON-state shimmer local dB (p = 0.01 and p < 0.01, respectively).Conclusions: Our findings emphasize that levodopa has a poor effect on speech acoustic parameters. The intensity and location of LID negatively influenced speech quality. |
topic |
acoustic analysis dysarthria dyskinesias levodopa Parkinson's disease speech |
url |
https://www.frontiersin.org/articles/10.3389/fneur.2020.616062/full |
work_keys_str_mv |
AT francescocavallieri dopaminergictreatmenteffectsondysarthricspeechacousticanalysisinacohortofpatientswithadvancedparkinsonsdisease AT francescocavallieri dopaminergictreatmenteffectsondysarthricspeechacousticanalysisinacohortofpatientswithadvancedparkinsonsdisease AT carlabudriesi dopaminergictreatmenteffectsondysarthricspeechacousticanalysisinacohortofpatientswithadvancedparkinsonsdisease AT carlabudriesi dopaminergictreatmenteffectsondysarthricspeechacousticanalysisinacohortofpatientswithadvancedparkinsonsdisease AT annalisagessani dopaminergictreatmenteffectsondysarthricspeechacousticanalysisinacohortofpatientswithadvancedparkinsonsdisease AT annalisagessani dopaminergictreatmenteffectsondysarthricspeechacousticanalysisinacohortofpatientswithadvancedparkinsonsdisease AT saracontardi dopaminergictreatmenteffectsondysarthricspeechacousticanalysisinacohortofpatientswithadvancedparkinsonsdisease AT saracontardi dopaminergictreatmenteffectsondysarthricspeechacousticanalysisinacohortofpatientswithadvancedparkinsonsdisease AT valentinafioravanti dopaminergictreatmenteffectsondysarthricspeechacousticanalysisinacohortofpatientswithadvancedparkinsonsdisease AT elisamenozzi dopaminergictreatmenteffectsondysarthricspeechacousticanalysisinacohortofpatientswithadvancedparkinsonsdisease AT elisamenozzi dopaminergictreatmenteffectsondysarthricspeechacousticanalysisinacohortofpatientswithadvancedparkinsonsdisease AT elisamenozzi dopaminergictreatmenteffectsondysarthricspeechacousticanalysisinacohortofpatientswithadvancedparkinsonsdisease AT sergepinto dopaminergictreatmenteffectsondysarthricspeechacousticanalysisinacohortofpatientswithadvancedparkinsonsdisease AT elenamoro dopaminergictreatmenteffectsondysarthricspeechacousticanalysisinacohortofpatientswithadvancedparkinsonsdisease AT francovalzania dopaminergictreatmenteffectsondysarthricspeechacousticanalysisinacohortofpatientswithadvancedparkinsonsdisease AT francescaantonelli dopaminergictreatmenteffectsondysarthricspeechacousticanalysisinacohortofpatientswithadvancedparkinsonsdisease AT francescaantonelli dopaminergictreatmenteffectsondysarthricspeechacousticanalysisinacohortofpatientswithadvancedparkinsonsdisease |
_version_ |
1724284123348992000 |